Aclaris therapeutics to participate in two september healthcare conferences

Wayne, pa., aug. 27, 2025 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the company will participate in two upcoming healthcare conferences in september. on wednesday september 3, 2025, at 1:00 pm edt, aclaris' chief executive officer dr. neal walker and other members of aclaris' senior leadership team will participate in a fireside chat during the cantor global healthcare conference in new york, ny.
ACRS Ratings Summary
ACRS Quant Ranking